Benzinga's Premium Memberships
-
Options & Volatility Edge
Options & Volatility Edge is for those people who want to make money using cost effective options trading strategies. This product is for anyone—novices and experts. If you understand how to enter an options trade, you need Options & Volatility Edge.
-
ETF Professor
The ETF Professor is truly an appropriate moniker, because the Professor spends hours everyday analyzing the charts of dozens of ETFs EVERY DAY.
-
Winning Stocks
Winning Stocks tracks and analyzes attractive stocks that are poised to make great returns for the average investor. Investors receive the right information at the right time, which provides them with the possibility for great gains and the potential to beat the market.
-
Real-Time Rumors
In this game, information is everything. You have to know what is happening before the Street begins trading against you utilizing the new information. We will provide you with that edge.
-
Chart-Caster
From novice to pro, Chart-Caster delivers over $11,000 per month* in profitable trade setups across all time-frames from which members can evaluate, select, and replicate within their own trading accounts.
From Benzinga's Newsdesk
- 04:55 PM Scripps Unveils Two Original Shows
- 04:54 PM Covidien Announces Pricing of $1.250 Billion Senior Notes Offering
- 4:54 PM Ford Says Its $13.7B of Auto Debt Will be Reduced to $10B by Mid-Decade
- 4:51 PM Guess? Guides FY13 Capex $115-130M, Had Seen $130-145M
- 4:49 PM Microsoft Opens Its Student Social Network To Public - IBD
- 4:49 PM PDF Solutions CFO Walker Returned from Leave of Absence
- 4:48 PM Xerox CEO: 'Will Continue to Pay a Dividend; Policy Won't Impact That' -CNBC
- 4:47 PM Xerox's CEO on CNBC Says Xerox is Dividend Company
- 4:47 PM PREVIEW: Jim Cramer to Interview CEO of Con Edison on Mad Money
- 4:45 PM Guess? Says European Climate is More Stable
- 04:45 PM Dell Plunges on Q1 Results; Stock Down 10%
- 4:44 PM Canadian Pacific Teamsters May Still Strike on Freight Trains -Bloomberg
- 04:42 PM Annaly Capital Management Says CEO Completed Cancer Treatment, Cancer is in Remission
- 4:40 PM Ford's Chairman Says Mulally Isn't Going Anywhere
- 04:39 PM Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream
Brain Trust
- Scripps Unveils Two Original Shows
- Covidien Announces Pricing of $1.250 Billion Senior Notes Offering
- Dell Plunges on Q1 Results; Stock Down 10%
- Annaly Capital Management Says CEO Completed Cancer Treatment, Cancer is in Remission
- Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream
- First Bancorp Names Richard Moore President and CEO
- MicroVision Receives Nasdaq Global Market Listing Deficiency Notice
- Liberty Declares Cash Distribution to Holders of 3.5% 2013 Notes on Motorola Mobility Acquisition
- Guess Jumps On Q1 Beat
- MicroVision Receives Nasdaq Global Market Listing Deficiency Notice
- Eaton Acquires Cooper Industries; More Consolidation to Come?
- Apple Manufacturer Hiring 35,000 Employees to Build…
- Top 4 NASDAQ Stocks In The Wireless Communications Industry With The Highest Cash
- Has Facebook's IPO Marked the End of the Social Media Bubble?
- Global Hunter Securities Initiates Coverage on 12 Dry Bulk Shipping Companies
- Facebook Gets Off to Rocky Start on Technicals
- How Apple Sellers Got Burned on Facebook
- Apple and Sony Join Forces for iPhone 5?
- Ivanhoe Mines Rallies Almost 11% on Chinese Easing Speculation
- The Strongest Small-Caps in the Market
